Innovative Drug Delivery Systems for Enhanced Therapeutic Efficacy in Cancers, Liver Disease and Psoriasis
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 20 April 2025 | Viewed by 563
Special Issue Editors
Interests: hybrid nanoparticles; transferrin; matrix metalloproteinases; immunomodulator; chemoimmunotherapy
Interests: drug delivery; cancer immunotherapy; cardiovascular disease; pharmaceutical science
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent data from the Global Burden of Disease (GBD) study on mortality and disability rates across countries indicate a rapidly increasing health and economic burden of cancers and liver disease in many parts of the world. Interestingly, researchers have found that patients with psoriasis had an increased risk of developing cancers, including colon, kidney, and liver cancers, etc. In addition, patients with severe psoriasis and developed cancer also had an increased overall risk of dying.
This Special Issue aims to explore the latest advancements in the drug delivery system and biopharmaceuticals specifically targeting cancers, liver disease, and psoriasis. The focus will be on innovative approaches, mechanisms of action, and clinical outcomes related to these therapies in challenging cancers, liver disease, and psoriasis. By providing a platform for original research articles and comprehensive reviews, this Special Issue seeks to foster a deeper understanding of the potential and limitations of drugs in these diseases, ultimately contributing to improved therapeutic strategies and patient outcomes.
In this Special Issue, we aim to collect submissions that focus on the drug delivery Systems for Enhanced Therapeutic Efficacy in cancers, liver disease, and psoriasis. Original research articles and reviews, including in vitro and in vivo evidence and clinical data, are welcome.
Dr. Xiaofei Xin
Dr. Lisha Liu
Dr. Yunfan Kong
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- lipid nanoparticles
- liposomes
- exosomes
- long-acting injections
- topical delivery
- supermolecules
- hydrogel
- nucleic acid therapeutics
- gene-editing therapeutics
- small molecules
- monoclonal antibody
- cell-based therapy
- biopharmaceuticals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
